Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Kim, Sooah ^a   Hwang, Jiwon ^b   Xuan, Jinhua ^a   Jung, Young Hoon ^a   Cha, Hoon Suk ^b   Kim, Kyoung Heon ^a  

^a Korea University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; CITRULLINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETHANOLAMINE; GLUTAMINE; GLYCEROL; HYDROXYLAMINE; LYSINE; MYRISTIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OCTADECANOL; PALMITIC ACID; PALMITOLEIC ACID; RIBITOL; RIBOSE; SALICYLALDEHYDE; SUCCINIC ACID; TEREPHTHALIC ACID; TRYPTOPHAN; TYROSINE; URACIL; XYLOSE; BIOLOGICAL MARKER;

ADULT; ANALYSIS OF VARIANCE; ANKYLOSING SPONDYLITIS; ARTHROCENTESIS; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GAS CHROMATOGRAPHY; GENE EXPRESSION PROFILING; GENETIC LINKAGE; GOUT; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; TIME OF FLIGHT MASS SPECTROMETRY; AREA UNDER THE CURVE; ARTHRITIS, RHEUMATOID; CASE CONTROL STUDY; CLUSTER ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISCRIMINANT ANALYSIS; INFLAMMATION; METABOLISM; METABOLOME; PREDICTIVE VALUE; PROCEDURES; REGRESSION ANALYSIS;

ADULT; AREA UNDER CURVE; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; DIAGNOSIS, DIFFERENTIAL; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; INFLAMMATION; LEAST-SQUARES ANALYSIS; MALE; METABOLOME; METABOLOMICS; PREDICTIVE VALUE OF TESTS; ROC CURVE; SYNOVIAL FLUID;

EID: 84902352360     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097501     Document Type: Article

References (39)

1. Cammarata RJ, Rodnan GP, Fennell RH (1967) Serum anti-γ-globulin and antinuclear factors in the aged. JAMA-J Am Med Assoc 199: 455-458.
2. Litwin SD, Singer JM (1965) Studies of the incidence and significance of anti-gamma globulin factors in the aging. Arthritis Rheum 8: 538-550.
3. Rantapaa-Dahlqvist S, de Jong BAW, Berglin E, Hallmans G, Wadell G, et al. (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48: 2741-2749. (Pubitemid 37280601)
4. Humphreys JH, Symmons DP (2012) Postpublication validation of the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: where do we stand? Curr Opin Rheumatol 25(2): 157-163.
5. Kallberg H, Padyukov L, Plenge RM, Ronnelid J, Gregersen PK, et al. (2007) Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 80: 867-875. (Pubitemid 46668455)
6. Teixeira VH, Olaso R, Martin-Magniette ML, Lasbleiz S, Jacq L, et al. (2009) Transcriptome analysis describing new immunity and defense genes in peripheral blood mononuclear cells of rheumatoid arthritis patients. PLOS ONE 4(8): e6803.
7. Tanino M, Matoba R, Nakamura S, Kameda H, Amano K, et al. (2009) Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cells. Biochem Biophys Res Commun 387: 261-265.
8. Villas-Boas SG, Roessner-Tunali U, Hansen MAE, Smedsgaard J, Nielsen J (2007) Metabolome Analysis: An Introduction. Hoboken, NJ: John Wiley and Sons, Inc.
9. Bogdanov M, Matson WR, Wang L, Matson T, Saunders-Pullman R, et al. (2008) Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 131: 389-396. (Pubitemid 351197614)
10. Zhang J, Bowers J, Liu LY, Wei SW, Gowda GAN, et al. (2012) Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods. PLOS ONE 7(1): e30181.
11. Chen TL, Xie GX, Wang XY, Fan J, Qiu YP, et al. (2011) Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics 10(7): M110.004945.
12. Huang ZZ, Lin L, Gao Y, Chen YJ, Yan XM, et al. (2011) Bladder cancer determination via two urinary metabolites: A biomarker pattern approach. Mol Cell Proteomics 10(10): M111.007922.
13. Bell JD, Sadler PJ, Morris VC, Levander OA (1991) Effect of aging and diet on proton NMR spectra of rat urine. Magn Reson Med 17: 414-422.
14. Connor SC, Hansen MK, Corner A, Smith RF, Ryan TE (2010) Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. Mol Biosyst 6: 909-921.
15. Holmes E, Wilson ID, Nicholson JK (2008) Metabolic phenotyping in health and disease. Cell 134: 714-717.
16. 1H NMR Spectroscopy-based interventional metabolic phenotyping: A cohort study of rheumatoid arthritis patients. J Proteome Res 9: 4545-4553.
17. Madsen RK, Lundstedt T, Gabrielsson J, Sennbro CJ, Alenius GM, et al. (2011) Diagnostic properties of metabolic perturbations in rheumatoid arthritis. Arthritis Res Ther 13.
18. Borenstein DG, Gibbs CA, Jacobs RP (1982) Gas-liquid chromatographic analysis of synovial fluid. Arthritis Rheum 25: 947-953.
19. Lee DY, Fiehn O (2008) High quality metabolomic data for Chlamydomonas reinhardtii . Plant Methods 4: 7.
20. Fiehn O, Wohlgemuth G, Scholz M, Kind T, Lee DY, et al. (2008) Quality control for plant metabolomics: reporting MSI-compliant studies. Plant J 53: 691-704. (Pubitemid 351224695)
21. Hutschenreuther A, Kiontke A, Birkenmeier G, Birkemeyer C (2012) Comparison of extraction conditions and normalization approaches for cellular metabolomics of adherent growing cells with GC-MS. Anal Methods 4: 1953-1963.
22. Lee DY, Park JJ, Barupal DK, Fiehn O (2012) System Response of Metabolic Networks in Chlamydomonas reinhardtii to Total Available Ammonium. Mol Cell Proteomics 11: 973-988.
23. Denkert C, Budczies J, Kind T, Weichert W, Tablack P, et al. (2006) Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res 66: 10795-10804. (Pubitemid 44876975)
24. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, et al. (2006) TM4 microarray software suite. Methods Enzymol 411: 134-193.
25. Umetrics AB (2005) User's Guide to SIMCA-P, SIMCA-P+ version 11.0. Umeå, Sweden: Umetrics AB.
26. Lalkhen AG, McCluskey A (2008) Clinical tests: sensitivity and specificity. Contin Educ Anaesth Crit Care Pain 8: 221-223.
27. Swets JA (1988) Measuring the accuracy of diagnostic systems. Science 240: 1285-1293.
28. Lasko TA, Bhagwat JG, Zou KH, Ohno-Machado L (2005) The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 38: 404-415. (Pubitemid 41405811)
29. Greiner M, Pfeiffer D, Smith RD (2000) Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 45: 23-41. (Pubitemid 30308338)
30. Mamas M, Dunn WB, Neyses L, Goodacre R (2011) The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch Toxicol 85: 5-17.
31. Madsen R, Lundstedt T, Trygg J (2010) Chemometrics in metabolomics-A review in human disease diagnosis. Anal Chim Acta 659: 23-33.
32. Vinayavekhin N, Homan EA, Saghatelian A (2010) Exploring Disease through Metabolomics. ACS Chem Biol 5: 91-103.
33. Zhai G, Wang-Sattler R, Hart DJ, Arden NK, Hakim AJ, et al. (2010) Serum branched-chain amino acid to histidine ratio: a novel metabolomic biomarker of knee osteoarthritis. Ann Rheum Dis 69: 1227-1231.
34. Hugle T, Kovacs H, Heijnen I, Daikeler T, Baisch U, et al. (2012) Synovial fluid metabolomics in different forms of arthritis assessed by nuclear magnetic resonance spectroscopy. Clin Exp Rheumatol 30: 240-245.
35. Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC, et al. (1996) Protein unfolding by peptidylarginine deiminase - Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem 271: 30709-30716.
36. Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, et al. (2002) Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology 41: 809-814. (Pubitemid 34822965)
37. Jetten MSM, Pitoc GA, Follettie MT, Sinskey AJ (1994) Regulation of phospho(enol)-pyruvate-and oxaloacetate-converting enzymes in Corynebacterium glutamicum. Appl Microbiol Biotechnol 41: 47-52. (Pubitemid 24107036)
38. Kremer JM, Lawrence DA, Jubiz W, Digiacomo R, Rynes R, et al. (1990) Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Arthritis Rheum 33: 810-820. (Pubitemid 20205760)
39. Xie GX, Chen TL, Qiu YP, Shi P, Zheng XJ, et al. (2012) Urine metabolite profiling offers potential early diagnosis of oral cancer. Metabolomics 8: 220-231.